Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

•This ESMO-EURACAN Clinical Practice Guideline provides key recommendations for managing nasopharyngeal cancer (NPC).•It covers screening, clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.•Treatment algorithms for locoregional and recurrent/metastatic NPC are...

Full description

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 32; no. 4; pp. 452 - 465
Main Authors Bossi, P., Chan, A.T., Licitra, L., Trama, A., Orlandi, E., Hui, E.P., Halámková, J., Mattheis, S., Baujat, B., Hardillo, J., Smeele, L., van Herpen, C., Castro, A., Machiels, J.-P.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.04.2021
Subjects
Clinical Practice Guidelines
diagnosis
follow-up
Follow-Up Studies
Humans
Medical Oncology
nasopharyngeal cancer
Nasopharyngeal Carcinoma - diagnosis
Nasopharyngeal Carcinoma - epidemiology
Nasopharyngeal Carcinoma - therapy
Nasopharyngeal Neoplasms - diagnosis
Nasopharyngeal Neoplasms - epidemiology
Nasopharyngeal Neoplasms - therapy
Neoplasm Staging
Societies, Medical
treatment
treatment
follow-up
diagnosis
nasopharyngeal cancer
Clinical Practice Guidelines
Online AccessGet full text

Cover

More Information
Summary:•This ESMO-EURACAN Clinical Practice Guideline provides key recommendations for managing nasopharyngeal cancer (NPC).•It covers screening, clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.•Treatment algorithms for locoregional and recurrent/metastatic NPC are provided.•Recommendations were compiled by the authors based on available scientific data and the authors' collective expert opinion.
Bibliography:SourceType-Books-1
ObjectType-Article-1
content type line 6
ObjectType-Instructional Material/Guideline-2
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2020.12.007